Kidney International,
Год журнала:
2024,
Номер
105(4), С. S117 - S314
Опубликована: Март 13, 2024
This
article
is
published
as
part
of
a
supplement
sponsored
by
Kidney
Disease:
Improving
Global
Outcomes
(KDIGO).
The
opinions
or
views
expressed
in
this
are
those
the
authors
and
do
not
necessarily
reflect
recommendations
International
Society
Nephrology
Elsevier.
Dosages,
indications,
methods
use
for
products
that
referred
to
may
their
clinical
experience
be
derived
from
professional
literature
other
sources.
Journal of Psychopharmacology,
Год журнала:
2016,
Номер
30(6), С. 495 - 553
Опубликована: Март 15, 2016
The
British
Association
for
Psychopharmacology
guidelines
specify
the
scope
and
target
of
treatment
bipolar
disorder.
second
version,
like
first,
is
based
explicitly
on
available
evidence
presented,
previous
Clinical
Practice
guidelines,
as
recommendations
to
aid
clinical
decision
making
practitioners:
they
may
also
serve
a
source
information
patients
carers.
are
presented
together
with
more
detailed
but
selective
qualitative
review
evidence.
A
consensus
meeting,
involving
experts
in
disorder
its
treatment,
reviewed
key
areas
considered
strength
implications.
were
drawn
up
after
extensive
feedback
from
participants
interested
parties.
supporting
was
rated.
cover
diagnosis
disorder,
management,
strategies
use
medicines
episodes,
relapse
prevention
stopping
treatment.
Oxford University Press eBooks,
Год журнала:
2023,
Номер
unknown
Опубликована: Ноя. 23, 2023
Abstract
The
2001
(first)
edition
of
this
Handbook
was
a
comprehensive
review
history,
research,
and
discussions
on
religion
health
through
the
year
2000.
Appendix
listed
1,200
separate
quantitative
studies
each
rated
in
quality
0–10
scale,
followed
by
about
2,000
references
an
extensive
index
for
rapid
topic
identification.
2012
(second)
systematically
updated
research
from
2000
to
2010,
with
number
then
reaching
thousands.
This
2023
(third)
is
most
scientifically
rigorous
date,
covering
best
published
2021
emphasis
prospective
randomized
controlled
trials.
Beginning
Foreword
Dr.
Howard
K.
Koh,
former
US
Assistant
Secretary
Health
Department
Human
Services,
nearly
600,000-word
volume
examines
almost
every
aspect
health,
reviewing
past
more
recent
relationship
between
outcomes.
Furthermore,
all
its
34
chapters
conclude
clinical
community
applications,
making
text
relevant
both
healthcare
professionals
(physicians,
nurses,
social
workers,
rehabilitation
therapists,
counselors,
psychologists,
sociologists,
etc.)
clergy
(community
clergy,
chaplains,
pastoral
etc.).
book’s
focuses
studies,
describing
study
single
line,
allowing
researchers
quickly
locate
existing
research.
It
should
not
be
surprising
that
two
decades
has
been
cited
health.
British Journal of Sports Medicine,
Год журнала:
2019,
Номер
53(11), С. 667 - 699
Опубликована: Май 16, 2019
Mental
health
symptoms
and
disorders
are
common
among
elite
athletes,
may
have
sport
related
manifestations
within
this
population
impair
performance.
cannot
be
separated
from
physical
health,
as
evidenced
by
mental
increasing
the
risk
of
injury
delaying
subsequent
recovery.
There
no
evidence
or
consensus
based
guidelines
for
diagnosis
management
in
athletes.
Diagnosis
must
differentiate
character
traits
particular
to
athletes
psychosocial
maladaptations.Management
strategies
should
address
all
contributors
consider
biopsychosocial
factors
relevant
maximise
benefit
minimise
harm.
Management
involve
both
treatment
affected
individual
optimising
environments
which
train
compete.
To
advance
a
more
standardised,
approach
an
International
Olympic
Committee
Consensus
Work
Group
critically
evaluated
current
state
science
provided
recommendations.
Australian & New Zealand Journal of Psychiatry,
Год журнала:
2015,
Номер
49(12), С. 1087 - 1206
Опубликована: Дек. 1, 2015
Objectives:
To
provide
guidance
for
the
management
of
mood
disorders,
based
on
scientific
evidence
supplemented
by
expert
clinical
consensus
and
formulate
recommendations
to
maximise
salience
utility.
Methods:
Articles
information
sourced
from
search
engines
including
PubMed
EMBASE,
MEDLINE,
PsycINFO
Google
Scholar
were
literature
known
disorders
committee
(MDC)
(e.g.,
books,
book
chapters
government
reports)
published
depression
bipolar
disorder
guidelines.
Information
was
reviewed
discussed
members
MDC
findings
then
formulated
into
consensus-based
guidance.
The
guidelines
subjected
rigorous
successive
consultation
external
review
involving:
advisors,
public,
key
stakeholders,
professional
bodies
specialist
groups
with
interest
in
disorders.
Results:
Royal
Australian
New
Zealand
College
Psychiatrists
practice
(Mood
Disorders
CPG)
up-to-date
advice
regarding
that
is
informed
experience.
Mood
CPG
intended
use
psychiatrists,
psychologists,
physicians
others
an
mental
health
care.
Conclusions:
Disorder
first
Clinical
Practice
Guideline
address
both
depressive
It
provides
within
evidence-based
framework,
consensus.
Committee:
Professor
Gin
Malhi
(Chair),
Darryl
Bassett,
Philip
Boyce,
Richard
Bryant,
Paul
Fitzgerald,
Dr
Kristina
Fritz,
Malcolm
Hopwood,
Bill
Lyndon,
Roger
Mulder,
Greg
Murray,
Porter
Associate
Ajeet
Singh.
International
advisors:
Carlo
Altamura,
Francesco
Colom,
Mark
George,
Guy
Goodwin,
McIntyre,
Ng,
John
O’Brien,
Harold
Sackeim,
Jan
Scott,
Nobuhiro
Sugiyama,
Eduard
Vieta,
Lakshmi
Yatham.
Marie-Paule
Austin,
Michael
Berk,
Yulisha
Byrow,
Helen
Christensen,
Nick
De
Felice,
A/Professor
Seetal
Dodd,
Megan
Galbally,
Josh
Geffen,
Hazell,
David
Horgan,
Felice
Jacka,
Gordon
Johnson,
Anthony
Jorm,
Jon-Paul
Khoo,
Jayashri
Kulkarni,
Cameron
Lacey,
Noeline
Latt,
Florence
Levy,
Andrew
Lewis,
Colleen
Loo,
Thomas
Mayze,
Linton
Meagher,
Mitchell,
Daniel
O’Connor,
Tim
Outhred,
Rowe,
Narelle
Shadbolt,
Martien
Snellen,
Tiller,
Watkins,
Raymond
Wu.
American Journal of Psychiatry,
Год журнала:
2013,
Номер
170(11), С. 1249 - 1262
Опубликована: Сен. 13, 2013
The
risk-benefit
profile
of
antidepressant
medications
in
bipolar
disorder
is
controversial.
When
conclusive
evidence
lacking,
expert
consensus
can
guide
treatment
decisions.
International
Society
for
Bipolar
Disorders
(ISBD)
convened
a
task
force
to
seek
recommendations
on
the
use
antidepressants
disorders.An
iteratively
developed
through
serial
consensus-based
revisions
using
Delphi
method.
Initial
survey
items
were
based
systematic
review
literature.
Subsequent
surveys
included
new
or
reworded
and
that
needed
be
rerated.
This
process
resulted
final
ISBD
Task
Force
clinical
disorder.There
striking
incongruity
between
wide
weak
base
efficacy
safety
drugs
disorder.
Few
well-designed,
long-term
trials
prophylactic
benefits
have
been
conducted,
there
insufficient
with
combined
mood
stabilizers.
A
major
concern
risk
switch
hypomania,
mania,
mixed
states.
Integrating
experience
members,
was
reached
12
statements
disorder.Because
limited
data,
could
not
make
broad
endorsing
but
acknowledged
individual
patients
may
benefit
from
antidepressants.
Regarding
safety,
serotonin
reuptake
inhibitors
bupropion
lower
rates
manic
than
tricyclic
tetracyclic
norepinephrine-serotonin
inhibitors.
frequency
severity
antidepressant-associated
elevations
appear
greater
I
II
Hence,
should
prescribed
only
as
an
adjunct
mood-stabilizing
medications.